Inotiv Inc (NOTV)
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
$0.01-26.00%
Close 2026-07-17 · 1-day change
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
QuarterlyIQ Insights · NOTV
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | Sep 2012 | Sep 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 507.4 | 513.0 | 490.7 | 572.4 | 547.7 | 89.6 | 60.5 | 43.6 | 26.3 | 24.2 | 20.4 | 22.7 | 24.6 | 22.1 | 28.2 | 33.1 |
| Total Revenues | — | — | — | — | 547.7 | 89.6 | 60.5 | 43.6 | 26.3 | 24.2 | 20.4 | 22.7 | 24.6 | 22.1 | 28.2 | 33.1 |
| Cost of Revenues | — | — | — | — | — | 59.4 | 42.2 | 29.6 | 18.2 | 16.5 | 16.0 | 15.2 | 16.6 | 15.0 | 21.4 | 22.6 |
| Gross Profit | — | — | — | — | — | 30.2 | 18.2 | 14.0 | 8.1 | 7.7 | 4.4 | 7.5 | 8.0 | 7.1 | 6.8 | 10.5 |
| Operating Expenses & Income | ||||||||||||||||
| R&D Expenses | — | — | — | — | — | 0.4 | 0.6 | 0.6 | 0.6 | 0.5 | 0.5 | 0.7 | 0.7 | 0.5 | 0.5 | 0.5 |
| Operating Income | (48.1) | (30.9) | (86.4) | (81.5) | (263.5) | (5.6) | (3.1) | (0.2) | 0.0 | 1.3 | (3.0) | 0.9 | 0.3 | 0.8 | (5.7) | 1.3 |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | 56.6 | 46.9 | 43.0 | 29.7 | 1.7 | 1.5 | 0.6 | 0.3 | 0.4 | 0.4 | 0.3 | 0.5 | 0.6 | 0.7 | 0.7 |
| Other Non-Operating Income / Expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | (0.7) | — |
| EBT, Incl. Unusual Items | (105.7) | (87.8) | (130.8) | (124.2) | (352.4) | 6.1 | (4.5) | (0.8) | (0.3) | 0.9 | (3.2) | 1.1 | (1.1) | 0.8 | (6.3) | 2.4 |
| Income Tax Expense | (18.8) | (19.1) | (21.9) | (19.3) | (15.2) | (4.8) | 0.1 | 0.0 | (0.1) | 0.0 | (0.0) | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 |
| Earnings from Continuing Operations | — | — | — | — | (337.3) | 10.9 | — | — | — | — | — | — | — | — | — | — |
| Net Income | ||||||||||||||||
| Minority Interest | — | — | (0.4) | 0.2 | (0.2) | 0.0 | — | — | — | — | — | — | — | — | — | — |
| Net Income | (87.0) | (68.6) | (108.4) | (105.1) | (337.0) | 10.9 | (4.7) | (0.8) | (0.2) | 0.9 | (3.2) | 1.1 | (1.1) | 0.8 | (6.3) | 2.3 |
| Per Share | ||||||||||||||||
| Basic EPS | (2.51) | (2.11) | (4.19) | (4.10) | (13.84) | 0.83 | (0.43) | (0.08) | (0.02) | 0.11 | (0.40) | 0.14 | (0.13) | 0.10 | (0.88) | (0.74) |
| Diluted EPS | (2.51) | (2.11) | (4.19) | (4.10) | (13.84) | 0.19 | (0.43) | (0.08) | (0.02) | 0.10 | (0.40) | 0.07 | (0.13) | 0.09 | (0.88) | (0.74) |
| Revenue per Share | 14.64 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 34.7 | 32.5 | 25.9 | 25.6 | 24.4 | 13.2 | 10.9 | 10.4 | 8.8 | 8.2 | 8.1 | 8.1 | 8.0 | 7.7 | 7.2 | 5.7 |
| Diluted Weighted Avg Shares | 34.7 | 32.5 | 25.9 | 25.6 | 24.4 | 13.9 | 10.9 | 10.4 | 8.8 | 8.7 | 8.1 | 8.8 | 8.0 | 8.4 | 7.2 | 5.7 |
| Supplemental | ||||||||||||||||
| EBITDA | — | 25.0 | (29.3) | (26.7) | (214.1) | 0.7 | 1.0 | 2.6 | 1.9 | 3.0 | (1.5) | 2.3 | 1.9 | 2.6 | (3.4) | 3.4 |
| EBIT | (48.1) | (30.9) | (86.4) | (81.5) | (263.5) | (5.6) | (3.1) | (0.2) | 0.0 | 1.3 | (3.0) | 0.9 | 0.3 | 0.8 | (5.7) | 1.3 |
| Effective Tax Rate | 17.7% | — | — | 15.6% | 4.3% | -78.1% | -3.2% | -0.5% | 23.6% | 2.6% | 0.4% | 1.3% | -0.7% | 2.0% | -0.0% | 2.1% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.